Survival according to early ctDNA dynamics in advanced breast cancer (ABC) treated with endocrine therapy (ET) and a CDK4/6 inhibitor (CDK4/6i)

被引：0

作者：

Martinez Saez, O. ^{[1
]}

Felip Falgas, E. ^{[2
]}

Cappelletti, M. ^{[3
]}

Tolosa, P. ^{[4
]}

Braso-Maristany, F. ^{[5
]}

Sanfeliu Torres, E. ^{[6
]}

Pascual, T. ^{[1
]}

Chic, N. ^{[1
]}

Vidal, M. ^{[1
]}

Adamo, B. ^{[1
]}

Munoz, M. ^{[1
]}

Faull, I. ^{[7
,8
]}

Odegaard, J. ^{[9
]}

Patel, G. ^{[10
]}

McEwen, R. ^{[11
]}

Carroll, D. ^{[11
]}

Ciruelos, E. M. ^{[4
]}

Generali, D. G. ^{[12
]}

Margeli Vila, M. ^{[13
]}

Prat, A. ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[2] Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Med Oncol Dept, Barcelona, Spain

[3] ASST Cremona Azienda Socio Sanitaria Terr, Dept Med Oncol, Cremona, Italy

[4] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

[5] IDIBAPS Inst Invest Biomed August Pi i Sunyer, Oncol Dept, Barcelona, Spain

[6] Hosp Clin Barcelona, Pathol, Barcelona, Spain

[7] Guardant Hlth, Med Dept, Barcelona, Spain

[8] Guardant Hlth, Business Dev, Barcelona, Spain

[9] Guardant Hlth, Clin Dev, Redwood City, CA USA

[10] AstraZeneca, Clin Dev Dept, Macclesfield, Cheshire, England

[11] AstraZeneca, Oncol R&D, Oncol, Cambridge, England

[12] ASST Cremona Azienda Sociosanit Terr, Dept Med Oncol, Cremona, CR, Italy

[13] Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Med Oncol Dept, Badalona, Spain

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.03.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10P

引用

页码：S127 / S128

页数：2

共 50 条

[1] Development of a combined clinical model to predict progression-free survival (PFS) in advanced breast cancer (ABC) treated with CDK4/6 inhibitors (CDK4/6i)
Martinez-Saez, O.
Menichetti, A.
Pare Brunet, L.
Griguolo, G.
Rodriguez Hernandez, A.
Pascual, T.
Dieci, M. V.
Conte, P. F.
Giorgi, C. A.
Braso-Maristany, F.
Chic, N.
Martinez, D.
Rodriguez, A.
Schettini, F.
Conte, B.
Vidal, M.
Adamo, B.
Munoz, M.
Prat, A.
Guarneri, V.
ANNALS OF ONCOLOGY, 2020, 31 : S76 - S76
[2] Circulating tumour DNA (ctDNA) dynamics using a standardized multi-gene panel in advanced breast cancer patients (pts) treated with CDK4/6 inhibitors (CDK4/6i)
Martinez-Saez, O.
Pascual, T.
Braso-Maristany, F.
Chic, N.
Gonzalez-Farre, B.
Sanfeliu, E.
Rodriguez, A.
Martinez, D.
Galvan, P.
Rodriguez Hernandez, A.
Schettini, F.
Conte, B.
Vidal, M. J.
Adamo, B.
Munoz, M.
Moreno, R.
Ciruelos, E. M.
Faull, I.
Odegaard, J.
Prat, A.
ANNALS OF ONCOLOGY, 2020, 31 : S17 - S17
[3] Radiation therapy (RT) induced toxicity in advanced breast cancer (ABC) patients treated with CDK4/6 inhibitors (CDK4/6is)
Stjepanovic, Neda
Thawer, Alia
Nathoo, Dilshad
Giffoni, Danilo
Romero, Maria
Lott, Anthony
Eisen, Andrea
Pezo, Rossanna
Jerzak, Katarzyna
Trudeau, Maureen
Gandhi, Sonal
Warner, Ellen
CANCER RESEARCH, 2021, 81 (04)
[4] Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
Mai, Nicholas
dos Anjos, Carlos H.
Razavi, Pedram
Safonov, Anton
Patil, Sujata
Chen, Yuan
Drago, Joshua Z.
Modi, Shanu
Bromberg, Jacqueline F.
Dang, Chau T.
Liu, Dazhi
Norton, Larry
Robson, Mark
Chandarlapaty, Sarat
Jhaveri, Komal
NPJ BREAST CANCER, 2024, 10 (01)
[5] AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) and prior CDK4/6i exposure: A translational investigation
Wander, Seth A.
Micalizzi, Douglas S.
Dubash, Taronish
Juric, Dejan
Spring, Laura M.
Vidula, Neelima
Keenan, Jennifer
Beeler, Maureen
Viscosi, Elene
Che, Dante
Fisher, Elizabeth L.
Hepp, Rachel A.
Moy, Beverly
Isakoff, Steven J.
Ellisen, Leif W.
Supko, Jeffrey G.
Maheswaran, Shyamala
Haber, Daniel A.
Bardia, Aditya
CANCER RESEARCH, 2022, 82 (04)
[6] Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET)
Rodriguez Hernandez, A.
Martinez Saez, O.
Braso-Maristany, F.
Pastor, B.
Potrony, M.
Moreno, L.
Grau, E.
Puig-Butille, J. A.
Sanchez, A.
Schettini, F.
Conte, B.
Chic, N.
Vidal Losada, M. J.
Munoz, M.
Balaguer, F.
Prat, A.
Adamo, B.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S657 - S658
[7] Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Martinez-Saez, Olga
Pascual, Tomas
Braso-Maristany, Fara
Chic, Nuria
Gonzalez-Farre, Blanca
Sanfeliu, Esther
Rodriguez, Adela
Martinez, Debora
Galvan, Patricia
Rodriguez, Anna Belen
Schettini, Francesco
Conte, Benedetta
Vidal, Maria
Adamo, Barbara
Martinez, Antoni
Munoz, Montserrat
Moreno, Reinaldo
Villagrasa, Patricia
Salvador, Fernando
Ciruelos, Eva M.
Faull, Iris
Odegaard, Justin I.
Prat, Aleix
NPJ BREAST CANCER, 2021, 7 (01)
[8] Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Olga Martínez-Sáez
Tomás Pascual
Fara Brasó-Maristany
Nuria Chic
Blanca González-Farré
Esther Sanfeliu
Adela Rodríguez
Débora Martínez
Patricia Galván
Anna Belén Rodríguez
Francesco Schettini
Benedetta Conte
Maria Vidal
Barbara Adamo
Antoni Martínez
Montserrat Muñoz
Reinaldo Moreno
Patricia Villagrasa
Fernando Salvador
Eva M. Ciruelos
Iris Faull
Justin I. Odegaard
Aleix Prat
npj Breast Cancer, 7
[9] Real-world (RW) outcomes of patients (pts) with advanced breast cancer (aBC) with and without resistance alterations (alts) detected in cell-free circulating tumor DNA (ctDNA) prior to CDK4/6 inhibitor (CDK4/6i) plus endocrine therapy (ET) treatment.
Wander, Seth Andrew
Weipert, Caroline M.
Liao, Jiemin
Safonov, Anton
Zhang, Nicole
Bardia, Aditya
Razavi, Pedram
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor
Malon, Diego
Molto, Consolacion
Prasla, Shopnil
Cuthbert, Danielle
Pathak, Neha
Berner-Wygoda, Yael
Di Lorio, Massimo
Li, Meredith
Savill, Jacqueline
Mittal, Abhenil
Amir, Eitan
Jhaveri, Kartik
Nadler, Michelle B.
BREAST CANCER RESEARCH AND TREATMENT, 2025, 210 (02) : 405 - 416

← 1 2 3 4 5 →